Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02482675 · ClinicalTrials.gov registry record · NA

Regulation of Postprandial Nitric Oxide Bioavailability and Vascular Function By Dairy Milk

A NA study, sponsored by Ohio State University.

Completed
Registry status
NA
Development phase
23
Enrollment target

NCT02482675 is a NA study that has completed, run by Ohio State University. The registered enrollment target is 23 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02482675, a NA study, has completed, sponsored by Ohio State University.

COMPLETED
Registry status
NA
Development phase
23 participants
Enrollment target

Study Summary

Cardiovascular disease (CVD) is the leading cause of death in the United States. Short-term increases in blood sugar, or postprandial hyperglycemia (PPH), affect blood vessel function and increase the risk of CVD. Greater intakes of dairy foods have been associated with a lower risk of CVD, but whether these effects occur directly or indirectly by displacing foods in the diet that might increase CVD risk is unclear. The health benefits of dairy on heart health are at least partly attributed to its ability to limit PPH and resulting PPH-mediated responses leading to vascular dysfunction. This provides rationale to further investigate dairy as a dietary strategy to reduce PPH and risk for CVD. The objective of this study is to define the extent to which dairy milk, and its whey and casein protein fractions, protect against postprandial vascular dysfunction by reducing oxidative stress responses that limit nitric oxide bioavailability to the vascular endothelium in adults with prediabetes.

Interventions

  • OTHER Glucose
  • OTHER Glucose with Non-fat Milk
  • OTHER Glucose with Whey Protein Isolate
  • OTHER Glucose with Sodium Caseinate

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2015-06
Est. Completion 2018-02
Phase NA

Sponsor

Ohio State University

552 total trials

What the Registry Record Tells You About NCT02482675

The ClinicalTrials.gov registry entry for NCT02482675 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 4 interventions - of which Glucose is the first listed.

NCT02482675 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02482675 about?

NCT02482675 is a clinical study titled "Regulation of Postprandial Nitric Oxide Bioavailability and Vascular Function By Dairy Milk". Cardiovascular disease (CVD) is the leading cause of death in the United States. Short-term increases in blood sugar, or postprandial hyperglycemia (PPH), affect blood vessel function and increase the risk of CVD. Greater intakes of dairy foods have been associated with a lower risk of CVD, but whet...

What is the current status of trial NCT02482675?

This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2015-06. Estimated completion is 2018-02.

What interventions are being tested in trial NCT02482675?

The interventions under investigation include: Glucose (OTHER), Glucose with Non-fat Milk (OTHER), Glucose with Whey Protein Isolate (OTHER), Glucose with Sodium Caseinate (OTHER).

Who is sponsoring clinical trial NCT02482675?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.